What is Inogen's pre-tax stock-based compensation cost?

Inogen (INGN) reported pre-tax stock-based compensation cost of $1.95M in Q1 2026.

How has Inogen's pre-tax stock-based compensation cost changed year-over-year?

Inogen's pre-tax stock-based compensation cost decreased by 9.2% year-over-year, from $2.15M to $1.95M.

What is the long-term trend for Inogen's pre-tax stock-based compensation cost?

Over 3 years (2021 to 2025), Inogen's pre-tax stock-based compensation cost has grown at a -9.9% compound annual growth rate (CAGR), from $10.94M to $8.01M.

Inogen INGN Pre-tax stock-based compensation cost

Pre-tax stock-based compensation cost at other companies

Viemed Healthcare, Inc.VMD

——

Other financials

Income statement

See full

Revenue$85.1M+3.4%

Gross profit$44.9M+1.7%

Operating income-$9.3M-21.9%

Net income-$8.3M-34.8%

EPS (diluted)-$0.30-20.0%

Balance sheet

See full

Cash & equivalents$93.1M-21.7%

Total debt$16.9M-11.9%

Total equity$182.9M-7.6%

Total assets$285.9M-7.3%

Cash flow

See full

Operating cash flow-$6.7M+60.2%

CapEx$210.0K-28.1%

Free cash flow-$6.9M+59.6%

Valuation

See full

Market cap$174.63M-9.7%

Enterprise value$98.45M-9.5%

P/S0.5×-0.1×

Profitability

See full

Gross margin52.8%-2.6pp

Operating margin-9.1%-0.8pp

Net margin-7.1%-0.8pp

FCF margin0.4%—

Returns & leverage

See full

Return on equity-13.1%-0.9pp

Debt / equity0.1×0.0×

Current ratio3.1×0.0×

Where this comes from

Reported directly by Inogen in its filing.

Tagged under the XBRL concept us-gaap:AllocatedShareBasedCompensationExpense.

The official record: Inogen’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Inogen's pre-tax stock-based compensation cost.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Inogen's pre-tax stock-based compensation cost?: Inogen (INGN) reported pre-tax stock-based compensation cost of $1.95M in Q1 2026.
How has Inogen's pre-tax stock-based compensation cost changed year-over-year?: Inogen's pre-tax stock-based compensation cost decreased by 9.2% year-over-year, from $2.15M to $1.95M.
What is the long-term trend for Inogen's pre-tax stock-based compensation cost?: Over 3 years (2021 to 2025), Inogen's pre-tax stock-based compensation cost has grown at a -9.9% compound annual growth rate (CAGR), from $10.94M to $8.01M.